Standard Contracts
AMENDED AND RESTATED SENIOR UNSECURED REVOLVING CREDIT AGREEMENT originally dated as of January 20, 2011 and Amended and Restated as of June 13 2011 among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEVA PHARMACEUTICALS USA, INC., TEVA FINANCE SERVICES...Senior Unsecured Revolving Credit Agreement • July 28th, 2011 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
This Amended and Restated Credit Agreement (this “Agreement”), originally dated as of January 20, 2011 and amended and restated as of June 13, 2011, is among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, an Israeli company registered under no 52-0013-954, the registered address of which is at Har Hozvim, Jerusalem, ISRAEL (the “Company” or “Parent”), TEVA PHARMACEUTICALS USA, INC., a Delaware corporation, the principal office of which is at 1090 Horsham Road, North Wales, Pennsylvania, United States of America (“Teva USA”), TEVA FINANCE SERVICES B.V., a Curaçao company registered under no. 105859 (0), the registered address of which is at Schottegatweg Oost 29 D, Curaçao (“Teva Curacao I”), TEVA FINANCE SERVICES II B.V., a Curaçao company registered under no. 119570 (0), the registered address of which is at Schottegatweg Oost 29 D, Curaçao (“Teva Curacao II”), Teva Capital Services Switzerland GmbH, a company organized under the laws of Switzerland, registered under no-320.4.062.063-3 (“Tev
BRIDGE LOAN AGREEMENT dated as of June 13, 2011 among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICAL FINANCE COMPANY B.V., TEVA PHARMACEUTICAL FINANCE N.V., as Borrowers, THE LENDERS PARTY HERETO FROM TIME...Bridge Loan Agreement • July 28th, 2011 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
This Bridge Loan Agreement (this “Agreement”), dated as of June 13, 2011, is among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, an Israeli company registered under no 52-0013-954, the registered address of which is at Har Hozvim, Jerusalem, ISRAEL (the “Company” or “Parent”), TEVA PHARMACEUTICALS USA, INC., a Delaware corporation, the principal office of which is at 1090 Horsham Road, North Wales, Pennsylvania, United States of America (“Teva USA”), TEVA PHARMACEUTICAL FINANCE COMPANY B.V., a Curaçao company registered under no. 98250 (0), the registered address of which is at Schottegatweg Oost 29 D, Curaçao (“Teva Curacao III”), TEVA PHARMACEUTICAL FINANCE N.V., a Curaçao company registered under no. 86707 (0), the registered address of which is at Schottegatweg Oost 29 D, Curaçao (“Teva Curacao IV”), the Additional Borrowers party hereto from time to time, the Lenders party hereto from time to time, CITIBANK, N.A. (the “Administrative Agent”) and HSBC BANK PLC, as Documentation Agent (th
TERM LOAN FACILITIES CREDIT AGREEMENT dated as of June 13, 2011 among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICAL FINANCE COMPANY B.V., TEVA PHARMACEUTICAL FINANCE N.V., as Borrowers, THE LENDERS PARTY...Term Loan Facilities Credit Agreement • July 28th, 2011 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
This Credit Agreement (this “Agreement”), dated as of June 13, 2011, is among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, an Israeli company registered under no 52-0013-954, the registered address of which is at Har Hozvim, Jerusalem, ISRAEL (the “Company” or “Parent”), TEVA PHARMACEUTICALS USA, INC., a Delaware corporation, the principal office of which is at 1090 Horsham Road, North Wales, Pennsylvania, United States of America (“Teva USA”), TEVA PHARMACEUTICAL FINANCE COMPANY B.V., a Curaçao company registered under no. 98250 (0), the registered address of which is at Schottegatweg Oost 29 D, Curaçao (“Teva Curacao III”), TEVA PHARMACEUTICAL FINANCE N.V., a Curaçao company registered under no. 86707 (0), the registered address of which is at Schottegatweg Oost 29 D, Curaçao (“Teva Curacao IV”), the Additional Borrowers party hereto from time to time, the Lenders party hereto from time to time, CITIBANK, N.A. (the “Administrative Agent”) and HSBC BANK PLC, as Documentation Agent (the “Do
1-YEAR SENIOR UNSECURED JAPANESE YEN REVOLVING CREDIT AGREEMENT dated as of July 6, 2011 among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, as Guarantor, ASAPH FARMACEUTISCHE ONDERNEMING B.V., as Initial Borrower, THE ADDITIONAL BORROWERS PARTY HERETO FROM...Revolving Credit Agreement • July 28th, 2011 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
This Credit Agreement (this “Agreement”), dated as of July 6, 2011, is among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, an Israeli company registered under no 52-0013-954, the registered address of which is at Har Hozvim, Jerusalem, ISRAEL (the “Company”, “Guarantor” or “Parent”), ASAPH FARMACEUTISCHE ONDERNEMING B.V., a private company with limited liability incorporated under the laws of The Netherlands registered under no. 30117451, the registered address which is at Computerweg 10, 3542DR Utrecht, The Netherlands, and a Subsidiary of the Company (“Teva Netherlands” or the “Initial Borrower”), the Additional Borrowers party hereto from time to time, the Lenders party hereto from time to time, and SUMITOMO MITSUI BANKING CORPORATION (the “Administrative Agent”).
FRAMEWORK AGREEMENTFramework Agreement • July 28th, 2011 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations
This FRAMEWORK AGREEMENT (the “Agreement”), is entered into as of May 16, 2011 by and among TAIYO Pharmaceutical Industry Co., Ltd., a company organized pursuant to the laws of Japan (“TAIYO”), and Asaph Farmaceutische Onderneming B.V., a private company with limited liability incorporated under the laws of The Netherlands (“Asaph”), and the following shareholders of TAIYO: Shigeki Aratani, Takeshi Aratani, Hisashi Aratani, Yasuyuki Aratani and Marudai Industries Co., Ltd. (“Marudai”) (such shareholders, collectively, the “Family Shareholders”, and together with TAIYO, “TAIYO Parties”). TAIYO Parties and Asaph are also referred to herein individually as a “Party” and collectively as the “Parties.”
